4//SEC Filing
NODELMAN OLEG 4
Accession 0000935836-25-000438
CIK 0001937653other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:50 PM ET
Size
12.6 KB
Accession
0000935836-25-000438
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
EcoR1 Capital, LLC
Director10% Owner
Transactions
- Tax Payment
Common Stock
2025-06-26$12.71/sh−41$521→ 22,970,388 total(indirect: See Note) - Exercise of In-Money
Pre-Funded Warrants (right to acquire)
2025-06-26−5,086,521→ 0 total(indirect: See note)Exercise: $0.00From: 2023-12-26→ Common Stock (5,086,521 underlying) - Exercise of In-Money
Common Stock
2025-06-26$0.00/sh+5,086,480$509→ 22,970,388 total(indirect: See Note)
NODELMAN OLEG
Director10% Owner
Transactions
- Exercise of In-Money
Pre-Funded Warrants (right to acquire)
2025-06-26−5,086,521→ 0 total(indirect: See note)Exercise: $0.00From: 2023-12-26→ Common Stock (5,086,521 underlying) - Tax Payment
Common Stock
2025-06-26$12.71/sh−41$521→ 22,970,388 total(indirect: See Note) - Exercise of In-Money
Common Stock
2025-06-26$0.00/sh+5,086,480$509→ 22,970,388 total(indirect: See Note)
Footnotes (6)
- [F1]The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.
- [F2]Qualified Fund acquired 4,818,424 shares of Common Stock in connection with the exercise of the pre-funded warrants.
- [F3]After the transactions reported herein, Qualified Fund held 21,582,563 shares of the Issuer's Common Stock.
- [F4]On June 26, 2025,the reporting persons exercised pre-funded warrants to purchase 5,086,521 shares of the Issuer's Common Stock for $0.0001 per share. The reporting persons paid the exercise price on a cashless basis, resulting in the Issuer withholding 41 of the warrant shares (including 38 warrant shares issuable to Qualified Fund) to pay the exercise price and issuing to the reporting persons the remaining 5,086,480 shares.
- [F5]Qualified Fund exercised 4,818,462 of the pre-funded warrants reported in this transaction.
- [F6]The pre-funded warrants did not have an expiration date.
Documents
Issuer
Zymeworks Inc.
CIK 0001937653
Entity typeother
Related Parties
1- filerCIK 0001454385
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 5:50 PM ET
- Size
- 12.6 KB